TrialBlood2006

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.

Yousif Matloub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.